Zobrazeno 1 - 10 of 14 pro vyhledávání: '"Basilio Rodríguez-Diez"'
1
Akademický článek
The impact of gout as described by patients, using the lens of The International Classification of Functioning, Disability and Health (ICF): a qualitative study
Autor: Isobel Cairns, Karen Lindsay, Nicola Dalbeth, Cesar Díaz-Torné, Maria Antònia Pou, Basilio Rodríguez Diez, Enriqueta Pujol-Ribera, Charlotte Panter, Rob Arbuckle, Sophi Tatlock, William J. Taylor
Publikováno v: BMC Rheumatology, Vol 4, Iss 1, Pp 1-9 (2020)
Abstract Background The International Classification of Functioning, Disability and Health (ICF) aims to comprehensively describe the ways in which a person’s health condition affects their life. This study aimed to contribute to the development of
Externí odkaz: https://doaj.org/article/18bfe99b2d8741cd99ceb24a02f8c49c
Zobrazit plný text záznamu
4
The impact of gout as described by patients, using the lens of The International Classification of Functioning, Disability and Health (ICF) : a qualitative study
Autor: Cesar Diaz-Torne, Basilio Rodríguez Diez, Nicola Dalbeth, Maria Antonia Pou, S Tatlock, William J. Taylor, Karen Lindsay, Rob Arbuckle, Charlotte Panter, Isobel Cairns, Enriqueta Pujol-Ribera
Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
BMC Rheumatology
BMC Rheumatology, Vol 4, Iss 1, Pp 1-9 (2020)
This project was supported by Arthritis New Zealand (grant reference R259 to WJT). The US data collection was funded by Pfizer (undertaken commercially by Adelphi Values). The NZ data collection was supported by the Maaori Gout Action Group of Counti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6b059ca4c77f1368391392dd8e90882
https://ddd.uab.cat/record/231287
Zobrazit plný text záznamu
7
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review
Autor: Paloma Vela Casasempere, Loreto Carmona, María Montoro, José Ivorra, FRANCISCO DEL POZO GUERRERO, Estefania Moreno Ruzafa, Juan D Cañete, Basilio Rodríguez-Diez, Raimon Sanmarti, Agustí Sellas, Juan Gomez-Reino, Antonio Naranjo Hernandez, Beatriz Pérez-Zafrilla
Publikováno v: Seminars in arthritis and rheumatism. 41(3)
Objectives To estimate the rate of demyelinating diseases in patients with rheumatic diseases treated with tumor necrosis factor (TNF) antagonists and to describe the cases reported to 3 different pharmacovigilance sources. Methods All confirmed case
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4962c974f20d53d4769b8c239b7a3134
https://pubmed.ncbi.nlm.nih.gov/22152489
Zobrazit plný text záznamu
8
Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0
Autor: Loreto Carmona, María Montoro, Juan D Cañete, Basilio Rodríguez-Diez, Raimon Sanmarti, Agustí Sellas, Juan Gomez-Reino, Antonio Naranjo Hernandez, Miguel A. Descalzo
Publikováno v: Annals of the rheumatic diseases. 71(3)
ObjectiveTo investigate in rheumatoid arthritis (RA) the rate and reason of discontinuation of tumour necrosis factor (TNF) antagonists over the past decade.MethodsRA patients in BIOBADASER 2.0 were stratified according to the start date of their fir
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb8199317bc073940e77cb6ace212f6
https://pubmed.ncbi.nlm.nih.gov/21998116
Zobrazit plný text záznamu
9
Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry
Autor: Xavier Suris, Andrés Ponce Fernández, Loreto Carmona, María Montoro, Juan D Cañete, Basilio Rodríguez-Diez, Agustí Sellas, Juan Gomez-Reino, Antonio Naranjo Hernandez, VERA ORTIZ-SANTAMARIA, Miguel A. Descalzo
Publikováno v: Rheumatology (Oxford, England). 50(11)
Objectives. To assess the retention rate of TNF antagonists in elderly patients suffering from chronic arthropathies and to identify predictive variables of discontinuation by inefficacy or by adverse events (AEs). Methods. All patients treated with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91564b564aa5427d91be449297a7b9cc
https://pubmed.ncbi.nlm.nih.gov/21856725
Zobrazit plný text záznamu
10
Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry
Autor: Paloma Vela Casasempere, Loreto Carmona, María Montoro, José Ivorra, Estefania Moreno Ruzafa, Juan D Cañete, Basilio Rodríguez-Diez, Raimon Sanmarti, Agustí Sellas, Juan Gomez-Reino, Antonio Naranjo Hernandez, Beatriz Pérez-Zafrilla, Miguel A. Descalzo, Enrique Casado
Publikováno v: Medicina clinica. 137(12)
Whether the use of tumor necrosis factor antagonists increases the risk of infection remains a subject of open debate. Developing effective strategies of prevention and empirical treatment entails carefully establishing the etiology and prognosis of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfde76ebf919008d67d93803a8b3466a
https://pubmed.ncbi.nlm.nih.gov/21514606
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje